Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013.

J Hematol Oncol · 2026 · PMC13224531 · PMID 42010655

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significancep = 0.18not close (p > 0.1)

In contrast, the IR patients consolidated with chemotherapy had a 3-year OS and EFS of 85.0% (95% CI, 73.1–91.9) and 75.9% (95% CI, 63.2–84.7), respectively; this difference did not reach statistical significance ( p = 0.18 and p = 0.08, respectively, supplementary Fig. 6 A and 6B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.